What are the emerging drug treatments for Parkinson’s disease (2)?

Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with parkinson disease and motor fluctuations: a randomized clinical trial Schapira AH, Fox SH, Hauser RA, et al. JAMA Neurol 2016; doi: 10.1001/jamaneurol.2016.4467 (Epub ahead of print). Abstract IMPORTANCE: Although levodopa remains the most effective oral pharmacotherapy for Parkinson disease (PD), its […]

via What are the emerging drug treatments for Parkinson’s disease (2)? — Neurochecklists Updates

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s